Related Experiment Video
Updated: Jun 2, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients
Lea S Eiland1, Thomas M English, Edward H Eiland
1Auburn University Harrison School of Pharmacy, Huntsville, AL, USA. eilanls@auburn.edu
Insights
Pediatric vancomycin dosing often leads to subtherapeutic levels. Increased dosages are necessary to achieve target vancomycin trough concentrations (10-20 mg/L) in children, addressing microbial resistance concerns.
Area of Science:
- Pediatric pharmacology
- Infectious disease management
Background:
- Rising microbial resistance to vancomycin necessitates higher therapeutic drug concentrations.
- Adult guidelines suggest increased vancomycin trough concentrations, principles applicable to pediatric care.
- Higher target serum concentrations require escalated vancomycin dosages in children.
Purpose of the Study:
- Evaluate current vancomycin dosing and resulting serum concentrations in pediatric patients.
- Compare pediatric vancomycin regimens against established guidelines.
- Develop a predictive equation for optimal vancomycin dosing in children.
Main Methods:
- Retrospective chart review of pediatric patients receiving vancomycin (2005-2010).
- Analysis of pharmacokinetic parameters, vancomycin dosages, and serum concentrations.
- Comparison of therapeutic serum concentrations with prescribing guidelines.
Main Results:
- Analysis of 435 trough concentrations from 295 pediatric patients.
- Vancomycin dosages averaged 48 mg/kg/day (2005-2008) and 59 mg/kg/day (2009-2010).
- Therapeutic vancomycin levels (5-15 mg/L) achieved in 78% (2005-2008) but only 49% (2009-2010) with 10-20 mg/L targets.
- A predictive equation suggests 70-85 mg/kg/day is needed for 10-15 mg/L trough concentrations.
Conclusions:
- Pediatric vancomycin dosing (40-60 mg/kg/day) often yields subtherapeutic levels based on current recommendations.
- Increased total daily vancomycin dosage is required to achieve target trough concentrations (10-20 mg/L).
- Optimized dosing is crucial for effective treatment and combating antimicrobial resistance in children.
Background:
Because of concerns regarding increasing microbial resistance to vancomycin, adult treatment guidelines recommend higher trough concentrations based on the type of infectious process. Although these recommendations are not specific to pediatrics, the principles can be extrapolated. Desired higher trough serum concentrations will require escalated dosages of vancomycin in children.
Objective:
To evaluate current dosing regimens and subsequent trough serum concentrations of vancomycin in children, compare these to reference recommended dosages and guidelines, and predict a dosing equation to achieve desired serum concentrations.
Methods:
Pharmacokinetic parameters of children in a community teaching hospital who were prescribed vancomycin from January 2005 to May 2010 were evaluated in this retrospective chart review. Vancomycin dosing and subsequent serum concentrations were analyzed. Therapeutic serum concentrations were evaluated and compared to vancomycin prescribing and monitoring guidelines by year.
Results:
Four hundred thirty-five trough serum concentrations determined in 295 patients were analyzed. The average dosages, when evaluated by year, were 48 mg/kg/day (2005-2008) and 59 mg/kg/day (2009-2010). Using trough concentration recommendations of 5-15 mg/L, vancomycin regimens provided therapeutic trough concentrations 78% of the time from 2005 to 2008. Using 10-20 mg/L as the trough recommendations in 2009-2010, only 49% of serum concentrations reached a therapeutic level. Based on our predictive equation for children aged 1 month-18 years with normal renal function, a vancomycin dosage of 70 mg/kg/day is required to provide trough serum concentrations of 10 mg/L; a dosage of 85 mg/kg/day is required to provide trough serum concentrations of 15 mg/L.
Conclusions:
Our institution was primarily using vancomycin dosing regimens that were recommended in pediatric references (40-60 mg/kg/day), which resulted in subtherapeutic serum concentrations in our population based on new monitoring recommendations. Considering that the currently desired therapeutic trough concentrations of vancomycin are 10-20 mg/L, the total daily dosage should be increased.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Estimation of k and VD of Aminoglycosides
Pharmacokinetics in Pediatric Patients: Drug Distribution
